Tag: Clinical Trials
Many Americans Have Reservations About Clinical Trials
Only 40 percent had favorable view of these studies, but number rose when they received more info
ASCO: Phase I Cancer Drug Trials Benefit From Precision Medicine
Better outcomes for patients whose treatment is selected based on molecular characteristics of tumor
Analytics Approach Could Improve Chemo Combinations
Two techniques indicate that models could improve efficacy of regimens for testing in phase III trials
Most Lung Cancer-Specific Tweets Relate to Support, Prevention
<20 percent of tweets about clinical trials; only one tweet linked to a patient recruitment website
Greater Transparency Being Promoted in Research
Move toward greater transparency has extended beyond medication products to other interventions
Finances Affect Patient Decisions About Cancer Clinical Trials
Greater financial concern linked to lower self-efficacy and preparation for decision making
Patient Education Ups Willingness to Consider Clinical Trials
PRE-ACT increases knowledge, reduces attitudinal barriers; linked to greater patient satisfaction
Industry Outpacing NIH in Funding Research
Analysis finds studies paid for by private sector increasing, while U.S.-sponsored trials decline
Industry-Led Oncology Trials May Inflate Cost-Effectiveness
Breast cancer cost-effectiveness analyses show favorable estimates with industry funding
Cardiovascular Trial Sponsorship Significantly Impacts Findings
Favorable outcomes seven times more likely in industry- versus NIH-sponsored trials
